For comments, suggestions
Created with Raphaël 2.1.0 17.08.2017 Filing date 08.03.2019 Validation fee payment 31.07.2019 (A1) Patent application published 14.12.2023 AGEPI application filing date 31.03.2024 (T2) Translation of the validated European patent 09.06.2026 17.08.2026 Valid until 18.08.2027 Renewal fee to be paid until 17.08.2037 Patent will expire on

Patent in force


(210)Number of the EPO application17758473
(220)Filing date of the EPO application2017.08.17
(80)EPO patent specification publication (B)EPB nr. 40/2023, 2023.10.04
(110)EPO patent number3500241
(11)Number of the documentMD 3500241 T2
(21)Number of the applicatione 2019 0710
(71)Name(s) of applicant(s), code of the countryCHIESI FARMACEUTICI S.P.A., IT;
(72)Name(s) of inventor(s), code of the countrySCURI Mario, IT;
COLI Pierfrancesco, IT;
DELMONTE Giuseppe, IT;
(73)Name(s) of owner(s), code of the countryCHIESI FARMACEUTICI S.P.A., IT;
(54)Title of the inventionCombination therapy for COPD
(13)Kind-of-document code T2
(51)International Patent Classification A61K 9/00 (2006.01.01); A61K 47/02 (2006.01.01); A61K 47/10 (2017.01.01); A61K 31/40 (2006.01.01); A61K 31/573 (2006.01.01); A61P 11/00 (2006.01.01); A61P 43/00 (2006.01.01); A61K 31/167 (2006.01.01)
(19)CountryIT
(41)Date of publication of the application2019.07.31
(49)Date of publication of the translation of the validated European patent specification2024.03.31
(30)Priority16184608, 2016.08.17, EP
(74)Patent attorney(Procedură) SKIDAN Natalia, Str. Andrei Doga 2/1, MD-2024, Chisinau, Republica Moldova
(86)International applicationPCT/EP2017/070850, 2017.08.17
(87)International publicationWO 2018/033598, 2018.02.22
Up
/Inventions/details/3500241